|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 421.55 INR | +0.97% |
|
+12.04% | +35.92% |
| 05-27 | SMS Pharmaceuticals Limited, Q4 2026 Earnings Call, May 27, 2026 | |
| 05-22 | SMS Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 35.11B 369M 322M 296M 276M 524M 532M 3.56B 1.38B 17.26B 1.38B 1.35B 59.46B | P/E 2024 |
30.3x | P/E 2025 | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.8B 397M 347M 319M 297M 564M 572M 3.83B 1.49B 18.58B 1.49B 1.46B 64.02B | EV / Sales 2024 |
2.47x | EV / Sales 2025 | 2.75x |
| Free-Float |
25.48% | Yield 2024 |
0.22% | Yield 2025 | 0.19% |
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | +0.97% | ||
| 1 week | +12.04% | ||
| Current month | +2.05% | ||
| 1 month | +19.15% | ||
| 3 months | +8.44% | ||
| 6 months | +29.55% | ||
| Current year | +35.92% |
| 1 week | 374.2 |  | 437.95 |
| 1 month | 365.5 | | 437.95 |
| Current year | 293.55 | | 446.5 |
| 1 year | 208.2 | | 446.5 |
| 3 years | 90.8 | | 446.5 |
| 5 years | 54.5 | | 446.5 |
| 10 years | 23.55 | | 446.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 1990-08-29 | |
| Director of Finance/CFO | - | 2017-09-12 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 1990-08-29 | |
| Director/Board Member | 37 | 2020-06-04 | |
| Director/Board Member | 48 | 2018-05-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | +12.04% | - | - | 415M | |
| +1.81% | +2.25% | +13.63% | +81.62% | 48B | |
| -2.54% | +3.72% | +66.86% | +116.52% | 36.89B | |
| +0.15% | +1.26% | -3.64% | +44.11% | 12.37B | |
| +3.71% | +3.56% | +13.95% | +98.68% | 11.95B | |
| +0.39% | +0.58% | +32.90% | +120.94% | 9.01B | |
| +0.66% | -0.57% | +19.74% | +46.69% | 7.2B | |
| +0.71% | +1.75% | +52.67% | -6.28% | 7.05B | |
| +9.99% | +32.94% | -15.50% | +25.64% | 6.58B | |
| +0.68% | +2.63% | +20.79% | +240.34% | 6.55B | |
| Average | +1.65% | +4.24% | +22.38% | +85.36% | 16.18B | |
| Weighted average by Cap. | +0.84% | +3.35% | +28.07% | +89.74% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.09B 74.49M 65.12M 59.85M 55.78M 106M 107M 718M 279M 3.49B 280M 274M 12.01B | 7.83B 82.21M 71.87M 66.05M 61.56M 117M 119M 793M 308M 3.85B 309M 302M 13.26B |
| Net income | 498M 5.23M 4.57M 4.2M 3.92M 7.43M 7.55M 50.47M 19.62M 245M 19.64M 19.22M 844M | 691M 7.26M 6.35M 5.83M 5.44M 10.31M 10.47M 70.03M 27.22M 340M 27.26M 26.67M 1.17B |
| Net Debt | 2.45B 25.7M 22.46M 20.64M 19.24M 36.5M 37.05M 248M 96.34M 1.2B 96.45M 94.38M 4.14B | 2.69B 28.28M 24.72M 22.72M 21.18M 40.17M 40.78M 273M 106M 1.32B 106M 104M 4.56B |
Employees
1,470
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | ₹421.55 | +0.97% | 16,254 |
| 26-07-02 | ₹417.50 | +1.93% | 15,323 |
| 26-07-01 | ₹409.60 | -0.85% | 69,222 |
| 26-06-30 | ₹413.10 | +8.58% | 183,080 |
| 26-06-29 | ₹380.45 | +1.12% | 7,044 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SMSPHARMA Stock
- SMSPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
